Nephrogenic systemic fibrosis / nephrogenic fibrosing dermopathy - Gadolinium lawsuits
Due to substantial documentation linking gadolinium with nephrogenic systemic fibrosis (NSF), also known as nephrogenic fibrosing dermopathy (NFD), the U.S. Food and Drug Administration (FDA) has required the representative manufacturers to issue black box warnings on their products. This warning is an official recognition by the government of the potentially fatal side effects of gadolinium associated with these contrast agents.
The inability for these manufacturers to properly produce and market a safe gadolinium product for their consumers may make them liable for any gadolinium lawsuits brought against them. During recent years there have been many of these cases brought against the responsible drug manufacturers to help consumers deal with rising medical costs.
The gadolinium lawyers at Levin, Simes, Kaiser & Gornick have decades of combined experience helping protect the rights of their clients. In the past, Bill Levin and Jeff Kaiser worked for a national law firm where they represented some of the country's biggest corporations. Prior to being a founding partner in one of the nation's leading personal injury firms, Laurel Simes devoted her own practice to ensuring the rights of working men and women and their families were protected. Larry Gornick brings years of trial experience dealing with a variety of areas, including false advertising, consumer class actions and product liability. If you think you have been subject to potentially dangerous gadolinium exposure, contact the consumer attorneys of Levin, Simes, Kaiser & Gornick today at (800) 901-4001.